Rationale Heterogeneity of the host response within sepsis, acute respiratory distress syndrome (ARDS) and more widely critical illness, limits discovery and targeting of immunomodulatory therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback